Supply Chain

A majority of U.S. workers feel confident they won't lose their jobs to automation, despite increased adoption among major companies, according to a survey from The Marist Poll and NPR.

Abbott Laboratories' net sales rose 42.3 percent to $7.59 billion in the fourth quarter ending Dec. 31, beating revenue projections of $7.39 billion, reports CNBC.

Baxter International, a saline bag supplier, issued an update Wednesday to customers on its efforts to mitigate shortages of saline products as the U.S. grapples with a severe flu season that is dramatically increasing demand, reports Reuters.

Here are seven articles Becker's Hospital Review published in the last week, highlighting the FDA's decision to extend the shelf life of several IV solutions in short supply and Congress' two-year delay of the medical device tax, among other topics.

Camp Hill, Pa.-based drugstore chain Rite Aid will pay $4 million to settle a U.S. Department of Justice criminal investigation into the improper sale of an ingredient often used to make methamphetamine, reports Reuters.

The FDA prolonged the shelf life of numerous IV solutions manufactured by Baxter International amid an ongoing nationwide shortage.

Amazon is expanding its healthcare team focused on a potential pharmacy market entrance, according to a report from the financial research firm Leerink cited by CNBC.

Drug companies are taking steps to address the growing threat of drug-resistant bacteria, but these actions are still in early phases, according to an analysis from the nonprofit group Access to Medicine Foundation.

Dan Liljenquist, vice president of the enterprise initiative office at Salt Lake City-based Intermountain Healthcare, is fully aware of the high costs and shortages of generic drugs.

Congress voted in favor of a stopgap spending bill Monday that ended the government shutdown and further delayed the enforcement of a 2.3 percent medical device tax, reports STAT.